Sanofi says ST400(**)(4) Proof of concept study read-out in Beta thalassemia H1 2021 BIVV003(**)( | SGMO Message Board Posts

Sangamo Therapeutics, Inc.

  SGMO website

SGMO   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  154540 of 156075  at  1/22/2021 12:37:53 PM  by

egomaniakos


 In response to msg 154533 by  sangamo
view thread

Re: Sanofi says ST400(**)(4) Proof of concept study read-out in Beta thalassemia H1 2021 BIVV003(**)(4) Proof of concept study read-out in Sickle Cell Disease H1 2021

Having put a lot of slides together I wonder about the fact that both are at the bottom of the list. As best as I can tell the list is not alphabetic or in order of development.

ego


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 3     Views: 0
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board

Replies
Msg # Subject Author Recs Date Posted
154541 Re: Sanofi says ST400(**)(4) Proof of concept study read-out in Beta thalassemia H1 2021 BIVV003(**)(4) Proof of concept study read-out in Sickle Cell Disease H1 2021 SFV 0 1/22/2021 1:15:04 PM
154542 Re: Sanofi says ST400(**)(4) Proof of concept study read-out in Beta thalassemia H1 2021 BIVV003(**)(4) Proof of concept study read-out in Sickle Cell Disease H1 2021 NewJeans 15 1/22/2021 1:20:19 PM
154543 Re: Sanofi says ST400(**)(4) Proof of concept study read-out in Beta thalassemia H1 2021 BIVV003(**)(4) Proof of concept study read-out in Sickle Cell Disease H1 2021 sangamo 2 1/22/2021 1:22:16 PM








Financial Market Data provided by
.
Loading...